Antonella Mancuso named chief manufacturing officer of Patheon; Allergan invests $350 million in plant in Ireland;

> Antonella Mancuso has been promoted to global commercial operations president and chief manufacturing officer for drug development and manufacturing services company Patheon ($PTI.TO). Release

> Allergan ($AGN) will invest about $350 million for a Botox manufacturing facility in Westport in County Mayo, Ireland, in the next four years. Eventually, it expects to have 1,050 working at the facility in the town of 6,000. Story

> Boehringer Ingelheim introduced what it calls a "Lean-to-Clinic" service, which it claims will deliver drug substances for toxicological and clinical studies in 13 months and drug products for clinical studies after 16 months. Release

> The FDA has updated its Q&A page to help manufacturers of topical antiseptics prevent contamination. Story

Suggested Articles

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.